Your browser doesn't support javascript.
loading
Relief of Urinary Symptom Burden after Primary Prostate Cancer Treatment.
Chang, Peter; Regan, Meredith M; Ferrer, Montserrat; Guedea, Ferran; Patil, Dattatraya; Wei, John T; Hembroff, Larry A; Michalski, Jeff M; Saigal, Chris S; Litwin, Mark S; Hamstra, Daniel A; Kaplan, Irving D; Ciezki, Jay P; Klein, Eric A; Kibel, Adam S; Sandler, Howard M; Dunn, Rodney L; Crociani, Catrina M; Sanda, Martin G.
Afiliación
  • Chang P; Department of Surgery, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts. Electronic address: pchang@bidmc.harvard.edu.
  • Regan MM; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
  • Ferrer M; Health Services Research Unit, Hospital del Mar Research Institute, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Barcelona, Spain; Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Guedea F; Department of Radiation Oncology, Institut Català d'Oncologia, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Patil D; Department of Urology, Emory University School of Medicine, Atlanta, Georgia.
  • Wei JT; Department of Urology, University of Michigan, Ann Arbor, Michigan.
  • Hembroff LA; Office for Survey Research, Institute for Public Policy and Social Research, Michigan State University, East Lansing, Michigan.
  • Michalski JM; Department of Radiation Oncology, Washington University, St. Louis, Missouri.
  • Saigal CS; Department of Urology, UCLA Center for Health Sciences, Los Angeles, California.
  • Litwin MS; Department of Urology, UCLA Center for Health Sciences, Los Angeles, California; Department of Health Policy and Management, UCLA Center for Health Sciences, Los Angeles, California.
  • Hamstra DA; Texas Center for Proton Therapy, Irving, Texas.
  • Kaplan ID; Department of Radiation Oncology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts.
  • Ciezki JP; Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio.
  • Klein EA; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio.
  • Kibel AS; Division of Urology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Sandler HM; Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, California.
  • Dunn RL; Department of Urology, University of Michigan, Ann Arbor, Michigan.
  • Crociani CM; Department of Surgery, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts.
  • Sanda MG; Department of Urology, Emory University School of Medicine, Atlanta, Georgia.
J Urol ; 197(2): 376-384, 2017 02.
Article en En | MEDLINE | ID: mdl-27593476
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Síntomas del Sistema Urinario Inferior Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: J Urol Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Síntomas del Sistema Urinario Inferior Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: J Urol Año: 2017 Tipo del documento: Article